Matthew Strobeck - Nov 5, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
Stock symbol
BDSX
Transactions as of
Nov 5, 2024
Transactions value $
$55,916
Form type
4
Date filed
11/6/2024, 03:16 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Purchase $5.59K +4K +4.67% $1.40 89.7K Nov 5, 2024 By Birchview Capital Separately Managed Account F1, F2
transaction BDSX Common Stock Purchase $50.3K +36K +1.4% $1.40 2.61M Nov 5, 2024 By Birchview Fund LLC F1, F2
holding BDSX Common Stock 2.54M Nov 5, 2024 Direct
holding BDSX Common Stock 119K Nov 5, 2024 By UTMA Account F3
holding BDSX Common Stock 119K Nov 5, 2024 By UTMA Account F3
holding BDSX Common Stock 119K Nov 5, 2024 By UTMA Account F3
holding BDSX Common Stock 119K Nov 5, 2024 By UTMA Account F3
holding BDSX Common Stock 40.7K Nov 5, 2024 By Clajer Capital LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 The Reporting Person is an affiliate of Clajer Capital LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.